Risk of common infections in people with inflammatory bowel disease in primary care: a population-based cohort study
ObjectiveTo evaluate the risk of common infections in individuals with inflammatory bowel disease (IBD) [ulcerative colitis and Crohn’s disease] compared with matched controls in a contemporary UK primary care population.DesignMatched cohort analysis (2014–2019) using the Royal College of General Pr...
Saved in:
Published in | BMJ open gastroenterology Vol. 8; no. 1; p. e000573 |
---|---|
Main Authors | , , , , |
Format | Journal Article |
Language | English |
Published |
England
BMJ Publishing Group Ltd
17.02.2021
BMJ Publishing Group LTD BMJ Publishing Group |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | ObjectiveTo evaluate the risk of common infections in individuals with inflammatory bowel disease (IBD) [ulcerative colitis and Crohn’s disease] compared with matched controls in a contemporary UK primary care population.DesignMatched cohort analysis (2014–2019) using the Royal College of General Practitioners Research and Surveillance Centre primary care database. Risk of common infections, viral infections and gastrointestinal infections (including a subset of culture-confirmed infections), and predictors of common infections, were evaluated using multivariable Cox proportional hazards models.Results18 829 people with IBD were matched to 73 316 controls. People with IBD were more likely to present to primary care with a common infection over the study period (46% vs 37% of controls). Risks of common infections, viral infections and gastrointestinal infections (including stool culture-confirmed infections) were increased for people with ulcerative colitis and Crohn’s disease compared with matched controls (HR range 1.12–1.83, all p<0.001). Treatment with oral glucocorticoid therapy, immunotherapies and biologic therapy, but not with aminosalicylates, was associated with increased infection risk in people with IBD. Despite mild lymphopenia and neutropenia being more common in people with IBD (18.4% and 1.9%, respectively) than in controls (6.5% and 1.5%, respectively), these factors were not associated with significantly increased infection risk in people with IBD.ConclusionPeople with IBD are more likely to present with a wide range of common infections. Health professionals and people with IBD should remain vigilant for infections, particularly when using systemic corticosteroids, immunotherapies or biologic agents.Trial registration numberClinicaltrials.gov (NCT03836612). |
---|---|
AbstractList | ObjectiveTo evaluate the risk of common infections in individuals with inflammatory bowel disease (IBD) [ulcerative colitis and Crohn’s disease] compared with matched controls in a contemporary UK primary care population.DesignMatched cohort analysis (2014–2019) using the Royal College of General Practitioners Research and Surveillance Centre primary care database. Risk of common infections, viral infections and gastrointestinal infections (including a subset of culture-confirmed infections), and predictors of common infections, were evaluated using multivariable Cox proportional hazards models.Results18 829 people with IBD were matched to 73 316 controls. People with IBD were more likely to present to primary care with a common infection over the study period (46% vs 37% of controls). Risks of common infections, viral infections and gastrointestinal infections (including stool culture-confirmed infections) were increased for people with ulcerative colitis and Crohn’s disease compared with matched controls (HR range 1.12–1.83, all p<0.001). Treatment with oral glucocorticoid therapy, immunotherapies and biologic therapy, but not with aminosalicylates, was associated with increased infection risk in people with IBD. Despite mild lymphopenia and neutropenia being more common in people with IBD (18.4% and 1.9%, respectively) than in controls (6.5% and 1.5%, respectively), these factors were not associated with significantly increased infection risk in people with IBD.ConclusionPeople with IBD are more likely to present with a wide range of common infections. Health professionals and people with IBD should remain vigilant for infections, particularly when using systemic corticosteroids, immunotherapies or biologic agents.Trial registration numberClinicaltrials.gov (NCT03836612). ObjectiveTo evaluate the risk of common infections in individuals with inflammatory bowel disease (IBD) [ulcerative colitis and Crohn’s disease] compared with matched controls in a contemporary UK primary care population.DesignMatched cohort analysis (2014–2019) using the Royal College of General Practitioners Research and Surveillance Centre primary care database. Risk of common infections, viral infections and gastrointestinal infections (including a subset of culture-confirmed infections), and predictors of common infections, were evaluated using multivariable Cox proportional hazards models.Results18 829 people with IBD were matched to 73 316 controls. People with IBD were more likely to present to primary care with a common infection over the study period (46% vs 37% of controls). Risks of common infections, viral infections and gastrointestinal infections (including stool culture-confirmed infections) were increased for people with ulcerative colitis and Crohn’s disease compared with matched controls (HR range 1.12–1.83, all p<0.001). Treatment with oral glucocorticoid therapy, immunotherapies and biologic therapy, but not with aminosalicylates, was associated with increased infection risk in people with IBD. Despite mild lymphopenia and neutropenia being more common in people with IBD (18.4% and 1.9%, respectively) than in controls (6.5% and 1.5%, respectively), these factors were not associated with significantly increased infection risk in people with IBD.ConclusionPeople with IBD are more likely to present with a wide range of common infections. Health professionals and people with IBD should remain vigilant for infections, particularly when using systemic corticosteroids, immunotherapies or biologic agents.Trial registration numberClinicaltrials.gov (NCT03835780). Objective To evaluate the risk of common infections in individuals with inflammatory bowel disease (IBD) [ulcerative colitis and Crohn’s disease] compared with matched controls in a contemporary UK primary care population.Design Matched cohort analysis (2014–2019) using the Royal College of General Practitioners Research and Surveillance Centre primary care database. Risk of common infections, viral infections and gastrointestinal infections (including a subset of culture-confirmed infections), and predictors of common infections, were evaluated using multivariable Cox proportional hazards models.Results 18 829 people with IBD were matched to 73 316 controls. People with IBD were more likely to present to primary care with a common infection over the study period (46% vs 37% of controls). Risks of common infections, viral infections and gastrointestinal infections (including stool culture-confirmed infections) were increased for people with ulcerative colitis and Crohn’s disease compared with matched controls (HR range 1.12–1.83, all p<0.001). Treatment with oral glucocorticoid therapy, immunotherapies and biologic therapy, but not with aminosalicylates, was associated with increased infection risk in people with IBD. Despite mild lymphopenia and neutropenia being more common in people with IBD (18.4% and 1.9%, respectively) than in controls (6.5% and 1.5%, respectively), these factors were not associated with significantly increased infection risk in people with IBD.Conclusion People with IBD are more likely to present with a wide range of common infections. Health professionals and people with IBD should remain vigilant for infections, particularly when using systemic corticosteroids, immunotherapies or biologic agents.Trial registration number Clinicaltrials.gov (NCT03835780). Objective To evaluate the risk of common infections in individuals with inflammatory bowel disease (IBD) [ulcerative colitis and Crohn’s disease] compared with matched controls in a contemporary UK primary care population. Design Matched cohort analysis (2014–2019) using the Royal College of General Practitioners Research and Surveillance Centre primary care database. Risk of common infections, viral infections and gastrointestinal infections (including a subset of culture-confirmed infections), and predictors of common infections, were evaluated using multivariable Cox proportional hazards models. Results 18 829 people with IBD were matched to 73 316 controls. People with IBD were more likely to present to primary care with a common infection over the study period (46% vs 37% of controls). Risks of common infections, viral infections and gastrointestinal infections (including stool culture-confirmed infections) were increased for people with ulcerative colitis and Crohn’s disease compared with matched controls (HR range 1.12–1.83, all p<0.001). Treatment with oral glucocorticoid therapy, immunotherapies and biologic therapy, but not with aminosalicylates, was associated with increased infection risk in people with IBD. Despite mild lymphopenia and neutropenia being more common in people with IBD (18.4% and 1.9%, respectively) than in controls (6.5% and 1.5%, respectively), these factors were not associated with significantly increased infection risk in people with IBD. Conclusion People with IBD are more likely to present with a wide range of common infections. Health professionals and people with IBD should remain vigilant for infections, particularly when using systemic corticosteroids, immunotherapies or biologic agents. Trial registration number Clinicaltrials.gov ( NCT03836612 ). To evaluate the risk of common infections in individuals with inflammatory bowel disease (IBD) [ulcerative colitis and Crohn's disease] compared with matched controls in a contemporary UK primary care population. Matched cohort analysis (2014-2019) using the Royal College of General Practitioners Research and Surveillance Centre primary care database. Risk of common infections, viral infections and gastrointestinal infections (including a subset of culture-confirmed infections), and predictors of common infections, were evaluated using multivariable Cox proportional hazards models. 18 829 people with IBD were matched to 73 316 controls. People with IBD were more likely to present to primary care with a common infection over the study period (46% vs 37% of controls). Risks of common infections, viral infections and gastrointestinal infections (including stool culture-confirmed infections) were increased for people with ulcerative colitis and Crohn's disease compared with matched controls (HR range 1.12-1.83, all p<0.001). Treatment with oral glucocorticoid therapy, immunotherapies and biologic therapy, but not with aminosalicylates, was associated with increased infection risk in people with IBD. Despite mild lymphopenia and neutropenia being more common in people with IBD (18.4% and 1.9%, respectively) than in controls (6.5% and 1.5%, respectively), these factors were not associated with significantly increased infection risk in people with IBD. People with IBD are more likely to present with a wide range of common infections. Health professionals and people with IBD should remain vigilant for infections, particularly when using systemic corticosteroids, immunotherapies or biologic agents. Clinicaltrials.gov (NCT03835780). |
Author | de Lusignan, Simon Tang, Daniel Nijher, Monica Irving, Peter M Barrett, Kevin |
AuthorAffiliation | 2 School of Immunology and Microbial Sciences , King's College London , London , UK 6 New Road Surgery , Croxley Green , Hertfordshire , UK 5 Pfizer Ltd , Tadworth , UK 4 Royal College of General Practitioners (RCGP) Research and Surveillance Centre (RSC) , London , UK 3 Nuffield Department of Primary Care Health Sciences , University of Oxford , Oxford , UK 1 Department of Gastroenterology , Guy's & St Thomas' Hospital , London , UK |
AuthorAffiliation_xml | – name: 1 Department of Gastroenterology , Guy's & St Thomas' Hospital , London , UK – name: 3 Nuffield Department of Primary Care Health Sciences , University of Oxford , Oxford , UK – name: 2 School of Immunology and Microbial Sciences , King's College London , London , UK – name: 4 Royal College of General Practitioners (RCGP) Research and Surveillance Centre (RSC) , London , UK – name: 5 Pfizer Ltd , Tadworth , UK – name: 6 New Road Surgery , Croxley Green , Hertfordshire , UK |
Author_xml | – sequence: 1 givenname: Peter M orcidid: 0000-0003-0972-8148 surname: Irving fullname: Irving, Peter M email: peter.irving@gstt.nhs.uk organization: School of Immunology and Microbial Sciences, King's College London, London, UK – sequence: 2 givenname: Simon surname: de Lusignan fullname: de Lusignan, Simon organization: Royal College of General Practitioners (RCGP) Research and Surveillance Centre (RSC), London, UK – sequence: 3 givenname: Daniel surname: Tang fullname: Tang, Daniel organization: Pfizer Ltd, Tadworth, UK – sequence: 4 givenname: Monica surname: Nijher fullname: Nijher, Monica organization: Pfizer Ltd, Tadworth, UK – sequence: 5 givenname: Kevin surname: Barrett fullname: Barrett, Kevin organization: New Road Surgery, Croxley Green, Hertfordshire, UK |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/33597152$$D View this record in MEDLINE/PubMed |
BookMark | eNqNkt1r1TAYxotM3Jz7CwQpeONNt3wn9UKQ4cdgIIhehzR5e06PbVOT1LH_3nQ9Hjcvhld5yft7Hp6E53lxNPoRiuIlRucYU3HRDLuNiakiiKAKIcQlfVKcEMRZxaRkR_fm4-Isxl1mMKeMEPWsOKaU1xJzclKkr138Ufq2tH4Y_Fh2Yws2dX6MeSwn8FMP5U2XtsumN8Ngkg-3ZeNvoC9dF8FEuCNDN5i8sCbA29KUk5_m3ixGVZMRl_23PqQyptndviietqaPcLY_T4vvHz98u_xcXX_5dHX5_rpqBBKposwSA8bWTNGGGNtIAg61WCGOQTWct7UQxMraYUwAFHUEYwekdVRkBaKnxdXq67zZ6X1E7U2n7y582GgTUmd70NbgpqWkFTT_mBTIYGOkFK5lPIewKnu9W72muRnAWRhTMP0D04ebsdvqjf-lpaqp4CQbvNkbBP9zhpj00EULfW9G8HPUhNUYSaLogr7-B935OYz5qzThqkZISVQ_SrEaMYaFWnLTlbLBxxigPUTGSC9V0vsq6aVKeq1SVr26_9qD5k9xMnC-Aln9n44XfwWHoI8pfgO-6uai |
CitedBy_id | crossref_primary_10_3390_biomedicines10123280 crossref_primary_10_1111_jdv_18841 crossref_primary_10_1093_crocol_otad061 crossref_primary_10_1093_ced_llac106 crossref_primary_10_1093_ibd_izae031 crossref_primary_10_1016_j_xops_2023_100411 crossref_primary_10_7554_eLife_93178 crossref_primary_10_1186_s12876_024_03273_0 crossref_primary_10_1038_s41398_022_02145_z crossref_primary_10_1016_j_jinf_2022_07_026 crossref_primary_10_1111_imj_16141 crossref_primary_10_1093_ecco_jcc_jjac141 crossref_primary_10_1038_s41575_022_00604_y crossref_primary_10_1016_j_coi_2023_102369 crossref_primary_10_1016_j_jcmgh_2023_03_005 crossref_primary_10_1016_j_ophtha_2022_05_008 crossref_primary_10_1097_MEG_0000000000002563 crossref_primary_10_2147_JIR_S342846 crossref_primary_10_1016_j_isci_2024_109173 crossref_primary_10_14309_ajg_0000000000002701 crossref_primary_10_1016_j_pathol_2021_09_023 crossref_primary_10_1016_j_clinbiochem_2021_11_011 crossref_primary_10_3389_fmicb_2022_856165 crossref_primary_10_1136_bmjgast_2023_001224 crossref_primary_10_1093_ecco_jcc_jjad085 crossref_primary_10_1111_apt_16905 crossref_primary_10_3390_nu15071742 crossref_primary_10_1111_apt_17674 crossref_primary_10_1002_jgh3_12841 crossref_primary_10_1093_ecco_jcc_jjad023 crossref_primary_10_1093_jcag_gwab032 crossref_primary_10_1080_21645515_2023_2208514 crossref_primary_10_1177_14782715231200503 crossref_primary_10_3390_tropicalmed9010013 crossref_primary_10_7759_cureus_53248 crossref_primary_10_1016_j_jvacx_2023_100374 crossref_primary_10_3389_fmicb_2022_801892 crossref_primary_10_7554_eLife_93178_3 crossref_primary_10_1186_s40001_023_01324_y crossref_primary_10_4103_CIDS_CIDS_62_23 |
Cites_doi | 10.3399/bjgp16X688573 10.1016/j.clnu.2016.12.027 10.1136/heartjnl-2019-316193 10.1016/j.crohns.2012.02.015 10.1038/ajg.2014.313 10.1007/s10096-019-03706-9 10.1038/ajg.2013.138 10.2165/00019053-200220100-00001 10.14236/jhi.v14i3.632 10.1016/j.cgh.2006.09.019 10.1371/journal.pmed.1002024 10.1136/gutjnl-2020-321244 10.1136/ebmental-2020-300167 10.1159/000366463 10.1038/ncpgasthep1004 10.1111/apt.13700 10.1093/ibd/izy131 10.1016/j.cgh.2006.03.002 10.2337/dc17-0542 10.1053/j.gastro.2008.01.012 10.1053/j.seminhematol.2013.06.010 10.1038/ajg.2009.581 10.1038/ajg.2012.406 10.1016/S0140-6736(17)32866-0 10.14236/jhi.v23i4.920 10.1038/s41590-019-0415-0 10.1002/ibd.21519 10.1136/bmjopen-2015-007974 10.1093/fampra/cmi106 10.1016/S2468-2667(17)30234-7 10.3389/fphar.2020.00314 10.1016/j.cgh.2017.10.008 10.1136/bmj.k872 10.1016/j.crohns.2013.12.013 10.1002/ibd.20449 10.1093/ije/dys188 10.1007/s10620-020-06071-2 10.1371/journal.pone.0155218 10.1016/S0140-6736(07)60751-X 10.1097/MIB.0b013e31828133fd 10.1053/j.gastro.2017.04.044 10.1136/bmjopen-2016-011092 10.14236/jhi.v19i3.805 10.1038/s41395-018-0211-8 10.1136/gutjnl-2019-318484 10.1016/S0140-6736(17)32448-0 10.1093/ibd/izy150 10.1136/gut.2004.041616 10.3748/wjg.v20.i12.3255 10.3748/wjg.v20.i1.6 10.1053/j.gastro.2018.04.012 10.1038/ajg.2012.218 10.1136/rmdopen-2020-001392 10.1016/j.cgh.2006.12.027 10.1371/journal.pmed.1002685 10.1111/apt.12182 10.3399/bjgp17X690425 10.1007/978-1-4757-3294-8 10.1093/rheumatology/kez344 10.1371/journal.pmed |
ContentType | Journal Article |
Copyright | Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. 2021 Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ . Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. 2021 |
Copyright_xml | – notice: Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. – notice: 2021 Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ . Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. – notice: Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. 2021 |
DBID | 9YT ACMMV NPM AAYXX CITATION 3V. 7X7 7XB 8FI 8FJ 8FK ABUWG AFKRA BENPR BTHHO CCPQU FYUFA GHDGH K9. PQEST PQQKQ PQUKI PRINS 7X8 5PM DOA |
DOI | 10.1136/bmjgast-2020-000573 |
DatabaseName | BMJ Journals (Open Access) BMJ Journals:Open Access PubMed CrossRef ProQuest Central (Corporate) Health & Medical Collection (Proquest) ProQuest Central (purchase pre-March 2016) Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni) ProQuest Central UK/Ireland ProQuest Central BMJ Journals ProQuest One Community College Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Health & Medical Complete (Alumni) ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central China MEDLINE - Academic PubMed Central (Full Participant titles) DOAJ Directory of Open Access Journals |
DatabaseTitle | PubMed CrossRef ProQuest One Academic Eastern Edition ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) ProQuest One Community College ProQuest Hospital Collection Health Research Premium Collection (Alumni) ProQuest Central China ProQuest Hospital Collection (Alumni) ProQuest Central ProQuest Health & Medical Complete Health Research Premium Collection ProQuest One Academic UKI Edition BMJ Journals ProQuest One Academic ProQuest Central (Alumni) MEDLINE - Academic |
DatabaseTitleList | ProQuest One Academic Eastern Edition MEDLINE - Academic CrossRef ProQuest One Academic Eastern Edition PubMed |
Database_xml | – sequence: 1 dbid: DOA name: DOAJ Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 2 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 3 dbid: ACMMV name: BMJ Journals:Open Access url: https://journals.bmj.com/ sourceTypes: Publisher – sequence: 4 dbid: 7X7 name: Health & Medical Collection (Proquest) url: https://search.proquest.com/healthcomplete sourceTypes: Aggregation Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 2054-4774 |
ExternalDocumentID | oai_doaj_org_article_ca1bf32f63774760a1aa776df45c2ac8 10_1136_bmjgast_2020_000573 33597152 ttps://bmjopengastro.bmj.com/content/8/1/e000573.full |
Genre | Journal Article |
GeographicLocations | United Kingdom--UK |
GeographicLocations_xml | – name: United Kingdom--UK |
GrantInformation_xml | – fundername: Pfizer Ltd grantid: NA – fundername: ; grantid: NA |
GroupedDBID | 53G 5VS 7X7 8FI 8FJ 9YT ABUWG ACGFS ACMMV ADBBV AFKRA ALIPV ALMA_UNASSIGNED_HOLDINGS AOIJS BCNDV BENPR BPHCQ BTHHO CCPQU DIK FYUFA GROUPED_DOAJ HMCUK HYE KQ8 M48 M~E OK1 PGMZT PQQKQ RHF RMJ RPM UKHRP ADRAZ NPM AAYXX CITATION 3V. 7XB 8FK K9. PQEST PQUKI PRINS 7X8 5PM |
ID | FETCH-LOGICAL-b606t-34c2aeac9483b2acb72ed0f18051e8b55f9662c79d112ee83d211de2fd3683b03 |
IEDL.DBID | RPM |
ISSN | 2054-4774 |
IngestDate | Thu Sep 05 15:40:52 EDT 2024 Tue Sep 17 21:13:13 EDT 2024 Fri Aug 16 04:55:40 EDT 2024 Fri Sep 13 10:10:18 EDT 2024 Fri Sep 13 05:57:45 EDT 2024 Fri Aug 23 01:32:43 EDT 2024 Sat Sep 28 08:24:54 EDT 2024 Wed Aug 21 03:31:59 EDT 2024 Tue Aug 20 23:24:41 EDT 2024 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 1 |
Keywords | primary care Crohn's disease ulcerative colitis inflammatory bowel disease |
Language | English |
License | This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/. Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-b606t-34c2aeac9483b2acb72ed0f18051e8b55f9662c79d112ee83d211de2fd3683b03 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
ORCID | 0000-0003-0972-8148 |
OpenAccessLink | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7893652/ |
PMID | 33597152 |
PQID | 2490441688 |
PQPubID | 2040973 |
ParticipantIDs | doaj_primary_oai_doaj_org_article_ca1bf32f63774760a1aa776df45c2ac8 pubmedcentral_primary_oai_pubmedcentral_nih_gov_7893652 proquest_miscellaneous_2491072832 proquest_journals_2589008709 proquest_journals_2490441688 crossref_primary_10_1136_bmjgast_2020_000573 pubmed_primary_33597152 bmj_primary_10_1136_bmjgast_2020_000573 bmj_journals_10_1136_bmjgast_2020_000573 |
PublicationCentury | 2000 |
PublicationDate | 2021-02-17 |
PublicationDateYYYYMMDD | 2021-02-17 |
PublicationDate_xml | – month: 02 year: 2021 text: 2021-02-17 day: 17 |
PublicationDecade | 2020 |
PublicationPlace | England |
PublicationPlace_xml | – name: England – name: London – name: BMA House, Tavistock Square, London, WC1H 9JR |
PublicationTitle | BMJ open gastroenterology |
PublicationTitleAbbrev | BMJ Open Gastro BMJ Open Gastroenterol |
PublicationTitleAlternate | BMJ Open Gastroenterol |
PublicationYear | 2021 |
Publisher | BMJ Publishing Group Ltd BMJ Publishing Group LTD BMJ Publishing Group |
Publisher_xml | – name: BMJ Publishing Group Ltd – name: BMJ Publishing Group LTD – name: BMJ Publishing Group |
References | Rahman, Marks, Hayee (R46) 2008; 14 Ning, Liu, Li (R39) 2020; 39 Axelrad, Joelson, Green (R44) 2018; 113 Fardet, Petersen, Nazareth (R62) 2016; 13 Hanada, Khanna, Loftus (R45) 2018; 16 Baumgart, Sandborn (R1) 2007; 369 Correa, Hinton, McGovern (R17) 2016; 6 Winthrop, Melmed, Vermeire (R58) 2018; 24 Galloway, Barrett, Irving (R24) 2020; 6 Rodemann, Dubberke, Reske (R41) 2007; 5 Toruner, Loftus, Harmsen (R7) 2008; 134 Pathirannehelage, Kumarapeli, Byford (R27) 2018; 247 Colombel (R57) 2018; 24 Tippu, Correa, Liyanage (R32) 2017; 23 Woodmansey, McGovern, McCullough (R23) 2017; 40 Amirthalingam, Andrews, Keel (R26) 2018; 3 Irving, Gibson (R50) 2008; 5 Denaxas, George, Herrett (R34) 2012; 41 Kennedy, Jones, Lamb (R8) 2020; 69 Lichtenstein, Feagan, Cohen (R11) 2006; 4 Ng, Shi, Hamidi (R4) 2018; 390 Vögelin, Biedermann, Frei (R59) 2016; 11 Chhaya, Saxena, Cecil (R61) 2016; 44 Crooks, West, Card (R9) 2015; 5 Xu, Liu, Feng (R47) 2014; 20 Kirchgesner, Lemaitre, Carrat (R55) 2018; 155 de Lusignan, Metsemakers, Houwink (R20) 2006; 14 Bassi, Dodd, Williamson (R3) 2004; 53 Brassard, Bitton, Suissa (R10) 2014; 109 Rahier, Magro, Abreu (R36) 2014; 8 de Lusignan, Correa, Pathirannehelage (R25) 2017; 67 de Lusignan, Liaw, Michalakidis (R18) 2011; 19 Nikiphorou, de Lusignan, Mallen (R21) 2020; 106 Ananthakrishnan, McGinley (R49) 2013; 7 (R53) 2017; 11 Coates, Wang, Pierscionek (R60) 2020; 11 Newburger, Dale (R33) 2013; 50 Nguyen, Patel, Chong (R38) 2010; 105 Nikiphorou, de Lusignan, Mallen (R52) 2019 Ford, Peyrin-Biroulet (R54) 2013; 108 Nikiphorou, de Lusignan, Mallen (R51) 2020; 106 Gupta, Lautenbach, Lewis (R14) 2006; 4 Lichtenstein, Feagan, Cohen (R12) 2012; 107 Irving, Barrett, Tang (R16) 2020 Abrahami, Douros, Yin (R30) 2018; 360 Long, Martin, Sandler (R56) 2013; 37 Ananthakrishnan, Cai, Savova (R28) 2013; 19 Kucharzik, Maaser (R6) 2014; 30 Limsrivilai, Saleh, Johnson (R40) 2020; 65 Neurath (R5) 2019; 20 Wallace, Zheng, Kanazawa (R48) 2014; 20 Warny, Helby, Nordestgaard (R15) 2018; 15 Bodger (R2) 2002; 20 Williams, Alexander, Armstrong (R22) 2018; 391 Stapley, Rubin, Alsina (R29) 2017; 67 Nguyen, Leung, Weizman (R37) 2011; 17 Lamb, Kennedy, Raine (R43) 2019; 68 Singh, Nugent, Yu (R42) 2017; 153 Forbes, Escher, Hébuterne (R63) 2017; 36 de Lusignan, van Weel (R19) 2006; 23 Long, Martin, Sandler (R13) 2013; 108 Newburger, Dale 2013; 50 Rahier, Magro, Abreu 2014; 8 Axelrad, Joelson, Green 2018; 113 Neurath 2019; 20 Xu, Liu, Feng 2014; 20 Irving, Gibson 2008; 5 Ananthakrishnan, Cai, Savova 2013; 19 Hanada, Khanna, Loftus 2018; 16 Denaxas, George, Herrett 2012; 41 Wallace, Zheng, Kanazawa 2014; 20 Stapley, Rubin, Alsina 2017; 67 Kennedy, Jones, Lamb 2020; 69 Baumgart, Sandborn 2007; 369 Nguyen, Patel, Chong 2010; 105 Nikiphorou, de Lusignan, Mallen 2019 Woodmansey, McGovern, McCullough 2017; 40 Nikiphorou, de Lusignan, Mallen 2020; 106 de Lusignan, van Weel 2006; 23 Toruner, Loftus, Harmsen 2008; 134 Bodger 2002; 20 Fardet, Petersen, Nazareth 2016; 13 Bassi, Dodd, Williamson 2004; 53 de Lusignan, Correa, Pathirannehelage 2017; 67 Ananthakrishnan, McGinley 2013; 7 Kirchgesner, Lemaitre, Carrat 2018; 155 Long, Martin, Sandler 2013; 37 Vögelin, Biedermann, Frei 2016; 11 Amirthalingam, Andrews, Keel 2018; 3 Pathirannehelage, Kumarapeli, Byford 2018; 247 Singh, Nugent, Yu 2017; 153 Lichtenstein, Feagan, Cohen 2006; 4 Rahman, Marks, Hayee 2008; 14 Warny, Helby, Nordestgaard 2018; 15 Coates, Wang, Pierscionek 2020; 11 Ng, Shi, Hamidi 2018; 390 Lichtenstein, Feagan, Cohen 2012; 107 Colombel 2018; 24 Chhaya, Saxena, Cecil 2016; 44 Brassard, Bitton, Suissa 2014; 109 Lamb, Kennedy, Raine 2019; 68 Nguyen, Leung, Weizman 2011; 17 Irving, Barrett, Tang 2020 Correa, Hinton, McGovern 2016; 6 de Lusignan, Metsemakers, Houwink 2006; 14 Ford, Peyrin-Biroulet 2013; 108 Kucharzik, Maaser 2014; 30 Tippu, Correa, Liyanage 2017; 23 Williams, Alexander, Armstrong 2018; 391 Galloway, Barrett, Irving 2020; 6 Winthrop, Melmed, Vermeire 2018; 24 Ning, Liu, Li 2020; 39 Rodemann, Dubberke, Reske 2007; 5 2017; 11 Limsrivilai, Saleh, Johnson 2020; 65 Gupta, Lautenbach, Lewis 2006; 4 Long, Martin, Sandler 2013; 108 Crooks, West, Card 2015; 5 de Lusignan, Liaw, Michalakidis 2011; 19 Forbes, Escher, Hébuterne 2017; 36 Abrahami, Douros, Yin 2018; 360 Ning (2024051413253676000_8.1.e000573.39) 2020; 39 Coates (2024051413253676000_8.1.e000573.60) 2020; 11 Chhaya (2024051413253676000_8.1.e000573.61) 2016; 44 2024051413253676000_8.1.e000573.1 2024051413253676000_8.1.e000573.2 2024051413253676000_8.1.e000573.3 2024051413253676000_8.1.e000573.4 2024051413253676000_8.1.e000573.7 2024051413253676000_8.1.e000573.8 2024051413253676000_8.1.e000573.15 2024051413253676000_8.1.e000573.59 2024051413253676000_8.1.e000573.14 2024051413253676000_8.1.e000573.17 2024051413253676000_8.1.e000573.11 2024051413253676000_8.1.e000573.55 2024051413253676000_8.1.e000573.54 2024051413253676000_8.1.e000573.13 2024051413253676000_8.1.e000573.12 2024051413253676000_8.1.e000573.56 2024051413253676000_8.1.e000573.50 Tippu (2024051413253676000_8.1.e000573.32) 2017; 23 2024051413253676000_8.1.e000573.52 Pathirannehelage (2024051413253676000_8.1.e000573.27) 2018; 247 2024051413253676000_8.1.e000573.19 Winthrop (2024051413253676000_8.1.e000573.58) 2018; 24 2024051413253676000_8.1.e000573.18 2024051413253676000_8.1.e000573.9 2024051413253676000_8.1.e000573.26 2024051413253676000_8.1.e000573.25 2024051413253676000_8.1.e000573.28 2024051413253676000_8.1.e000573.22 Neurath (2024051413253676000_8.1.e000573.5) 2019; 20 2024051413253676000_8.1.e000573.21 2024051413253676000_8.1.e000573.24 2024051413253676000_8.1.e000573.23 2024051413253676000_8.1.e000573.63 Colombel (2024051413253676000_8.1.e000573.57) 2018; 24 Kucharzik (2024051413253676000_8.1.e000573.6) 2014; 30 2024051413253676000_8.1.e000573.29 2024051413253676000_8.1.e000573.37 2024051413253676000_8.1.e000573.36 Irving (2024051413253676000_8.1.e000573.16) 2020 2024051413253676000_8.1.e000573.38 2024051413253676000_8.1.e000573.33 2024051413253676000_8.1.e000573.35 2024051413253676000_8.1.e000573.34 2024051413253676000_8.1.e000573.31 2024051413253676000_8.1.e000573.30 Singh (2024051413253676000_8.1.e000573.42) 2017; 153 Brassard (2024051413253676000_8.1.e000573.10) 2014; 109 Nikiphorou (2024051413253676000_8.1.e000573.51) 2020; 106 Hanada (2024051413253676000_8.1.e000573.45) 2018; 16 2024051413253676000_8.1.e000573.48 2024051413253676000_8.1.e000573.47 2024051413253676000_8.1.e000573.49 de Lusignan (2024051413253676000_8.1.e000573.20) 2006; 14 2024051413253676000_8.1.e000573.44 2024051413253676000_8.1.e000573.43 2024051413253676000_8.1.e000573.46 (2024051413253676000_8.1.e000573.53) 2017; 11 2024051413253676000_8.1.e000573.41 Fardet (2024051413253676000_8.1.e000573.62) 2016; 13 Limsrivilai (2024051413253676000_8.1.e000573.40) 2020; 65 |
References_xml | – volume: 67 start-page: e29 year: 2017 ident: R25 article-title: RCGP research and surveillance centre annual report 2014-2015: disparities in presentations to primary care publication-title: Br J Gen Pract doi: 10.3399/bjgp16X688573 contributor: fullname: Pathirannehelage – volume: 36 start-page: 321 year: 2017 ident: R63 article-title: ESPEN guideline: clinical nutrition in inflammatory bowel disease publication-title: Clin Nutr doi: 10.1016/j.clnu.2016.12.027 contributor: fullname: Hébuterne – volume: 106 start-page: 1566 year: 2020 ident: R21 article-title: Cardiovascular risk factors and outcomes in early rheumatoid arthritis: a population-based study publication-title: Heart doi: 10.1136/heartjnl-2019-316193 contributor: fullname: Mallen – volume: 7 start-page: 107 year: 2013 ident: R49 article-title: Infection-related hospitalizations are associated with increased mortality in patients with inflammatory bowel diseases publication-title: J Crohns Colitis doi: 10.1016/j.crohns.2012.02.015 contributor: fullname: McGinley – volume: 109 start-page: 1795 year: 2014 ident: R10 article-title: Oral corticosteroids and the risk of serious infections in patients with elderly-onset inflammatory bowel diseases publication-title: Am J Gastroenterol doi: 10.1038/ajg.2014.313 contributor: fullname: Suissa – volume: 39 start-page: 219 year: 2020 ident: R39 article-title: Increased risk of herpes zoster infection in patients with inflammatory bowel disease: a meta-analysis of cohort studies publication-title: Eur J Clin Microbiol Infect Dis doi: 10.1007/s10096-019-03706-9 contributor: fullname: Li – volume: 108 start-page: 1268 year: 2013 ident: R54 article-title: Opportunistic infections with anti-tumor necrosis factor-α therapy in inflammatory bowel disease: meta-analysis of randomized controlled trials publication-title: Am J Gastroenterol doi: 10.1038/ajg.2013.138 contributor: fullname: Peyrin-Biroulet – volume: 20 start-page: 639 year: 2002 ident: R2 article-title: Cost of illness of Crohn's disease publication-title: Pharmacoeconomics doi: 10.2165/00019053-200220100-00001 contributor: fullname: Bodger – volume: 14 start-page: 203 year: 2006 ident: R20 article-title: Routinely collected general practice data: goldmines for research? A report of the European Federation for medical informatics primary care informatics Working Group (EFMI PCIWG) from MIE2006, Maastricht, the Netherlands publication-title: Inform Prim Care doi: 10.14236/jhi.v14i3.632 contributor: fullname: Houwink – volume: 4 start-page: 1483 year: 2006 ident: R14 article-title: Incidence and risk factors for herpes zoster among patients with inflammatory bowel disease publication-title: Clin Gastroenterol Hepatol doi: 10.1016/j.cgh.2006.09.019 contributor: fullname: Lewis – volume: 13 year: 2016 ident: R62 article-title: Common infections in patients prescribed systemic glucocorticoids in primary care: a population-based cohort study publication-title: PLoS Med doi: 10.1371/journal.pmed.1002024 contributor: fullname: Nazareth – volume: 11 start-page: S338 year: 2017 ident: R53 article-title: P509 IBD cancer and serious infections in Europe (I-care): a European prospective observational study publication-title: Journal of Crohn’s and Colitis – volume: 69 start-page: 984 year: 2020 ident: R8 article-title: British Society of gastroenterology guidance for management of inflammatory bowel disease during the COVID-19 pandemic publication-title: Gut doi: 10.1136/gutjnl-2020-321244 contributor: fullname: Lamb – year: 2020 ident: R16 article-title: Common infections, mental health problems and healthcare use in people with inflammatory bowel disease: a cohort study protocol publication-title: Evid Based Ment Health doi: 10.1136/ebmental-2020-300167 contributor: fullname: Tang – year: 2019 ident: R52 article-title: Haematological abnormalities in new-onset rheumatoid arthritis and risk of common infections: a population-based study publication-title: Rheumatology contributor: fullname: Mallen – volume: 30 start-page: 6 year: 2014 ident: R6 article-title: Infections and chronic inflammatory bowel disease publication-title: Viszeralmedizin doi: 10.1159/000366463 contributor: fullname: Maaser – volume: 5 start-page: 18 year: 2008 ident: R50 article-title: Infections and IBD publication-title: Nat Clin Pract Gastroenterol Hepatol doi: 10.1038/ncpgasthep1004 contributor: fullname: Gibson – volume: 44 start-page: 482 year: 2016 ident: R61 article-title: Steroid dependency and trends in prescribing for inflammatory bowel disease - a 20-year national population-based study publication-title: Aliment Pharmacol Ther doi: 10.1111/apt.13700 contributor: fullname: Cecil – volume: 24 start-page: 2258 year: 2018 ident: R58 article-title: Herpes zoster infection in patients with ulcerative colitis receiving tofacitinib publication-title: Inflamm Bowel Dis doi: 10.1093/ibd/izy131 contributor: fullname: Vermeire – volume: 4 start-page: 621 year: 2006 ident: R11 article-title: Serious infections and mortality in association with therapies for Crohn's disease: treat registry publication-title: Clin Gastroenterol Hepatol doi: 10.1016/j.cgh.2006.03.002 contributor: fullname: Cohen – volume: 40 start-page: 1486 year: 2017 ident: R23 article-title: Incidence, demographics, and clinical characteristics of diabetes of the exocrine pancreas (type 3C): a retrospective cohort study publication-title: Diabetes Care doi: 10.2337/dc17-0542 contributor: fullname: McCullough – volume: 134 start-page: 929 year: 2008 ident: R7 article-title: Risk factors for opportunistic infections in patients with inflammatory bowel disease publication-title: Gastroenterology doi: 10.1053/j.gastro.2008.01.012 contributor: fullname: Harmsen – volume: 50 start-page: 198 year: 2013 ident: R33 article-title: Evaluation and management of patients with isolated neutropenia publication-title: Semin Hematol doi: 10.1053/j.seminhematol.2013.06.010 contributor: fullname: Dale – volume: 105 start-page: 371 year: 2010 ident: R38 article-title: Increased prevalence of and associated mortality with methicillin-resistant Staphylococcus aureus among hospitalized IBD patients publication-title: Am J Gastroenterol doi: 10.1038/ajg.2009.581 contributor: fullname: Chong – volume: 108 start-page: 240 year: 2013 ident: R13 article-title: Increased risk of pneumonia among patients with inflammatory bowel disease publication-title: Am J Gastroenterol doi: 10.1038/ajg.2012.406 contributor: fullname: Sandler – volume: 391 start-page: 1097 year: 2018 ident: R22 article-title: Disease burden and costs from excess alcohol consumption, obesity, and viral hepatitis: fourth report of the Lancet standing Commission on liver disease in the UK publication-title: Lancet doi: 10.1016/S0140-6736(17)32866-0 contributor: fullname: Armstrong – volume: 23 start-page: 799 year: 2017 ident: R32 article-title: Ethnicity recording in primary care computerised medical record systems: an ontological approach publication-title: J Innov Health Inform doi: 10.14236/jhi.v23i4.920 contributor: fullname: Liyanage – volume: 20 start-page: 970 year: 2019 ident: R5 article-title: Targeting immune cell circuits and trafficking in inflammatory bowel disease publication-title: Nat Immunol doi: 10.1038/s41590-019-0415-0 contributor: fullname: Neurath – volume: 17 start-page: 1338 year: 2011 ident: R37 article-title: Increased risk of vancomycin-resistant Enterococcus (VRE) infection among patients hospitalized for inflammatory bowel disease in the United States publication-title: Inflamm Bowel Dis doi: 10.1002/ibd.21519 contributor: fullname: Weizman – volume: 5 year: 2015 ident: R9 article-title: A comparison of the recording of comorbidity in primary and secondary care by using the Charlson index to predict short-term and long-term survival in a routine linked data cohort publication-title: BMJ Open doi: 10.1136/bmjopen-2015-007974 contributor: fullname: Card – volume: 23 start-page: 253 year: 2006 ident: R19 article-title: The use of routinely collected computer data for research in primary care: opportunities and challenges publication-title: Fam Pract doi: 10.1093/fampra/cmi106 contributor: fullname: van Weel – volume: 3 start-page: e82 year: 2018 ident: R26 article-title: Evaluation of the effect of the herpes zoster vaccination programme 3 years after its introduction in England: a population-based study publication-title: Lancet Public Health doi: 10.1016/S2468-2667(17)30234-7 contributor: fullname: Keel – volume: 11 year: 2020 ident: R60 article-title: Time- and race-specific haematological reference intervals for healthy volunteer trials: a retrospective analysis of pooled data from multiple phase I trials publication-title: Front Pharmacol doi: 10.3389/fphar.2020.00314 contributor: fullname: Pierscionek – volume: 16 start-page: 528 year: 2018 ident: R45 article-title: Non-Clostridium difficile bacterial infections are rare in patients with flares of inflammatory bowel disease publication-title: Clin Gastroenterol Hepatol doi: 10.1016/j.cgh.2017.10.008 contributor: fullname: Loftus – volume: 247 start-page: 161 year: 2018 ident: R27 article-title: Uptake of a Dashboard designed to give RealTime feedback to a sentinel network about key data required for influenza vaccine effectiveness studies publication-title: Stud Health Technol Inform contributor: fullname: Byford – volume: 360 year: 2018 ident: R30 article-title: Dipeptidyl peptidase-4 inhibitors and incidence of inflammatory bowel disease among patients with type 2 diabetes: population based cohort study publication-title: BMJ doi: 10.1136/bmj.k872 contributor: fullname: Yin – volume: 8 start-page: 443 year: 2014 ident: R36 article-title: Second European evidence-based consensus on the prevention, diagnosis and management of opportunistic infections in inflammatory bowel disease publication-title: J Crohns Colitis doi: 10.1016/j.crohns.2013.12.013 contributor: fullname: Abreu – volume: 14 start-page: 1443 year: 2008 ident: R46 article-title: Phagocyte dysfunction and inflammatory bowel disease publication-title: Inflamm Bowel Dis doi: 10.1002/ibd.20449 contributor: fullname: Hayee – volume: 41 start-page: 1625 year: 2012 ident: R34 article-title: Data resource profile: cardiovascular disease research using linked bespoke studies and electronic health records (caliber) publication-title: Int J Epidemiol doi: 10.1093/ije/dys188 contributor: fullname: Herrett – volume: 65 start-page: 3287 year: 2020 ident: R40 article-title: Prevalence and effect of intestinal infections detected by a PCR-based stool test in patients with inflammatory bowel disease publication-title: Dig Dis Sci doi: 10.1007/s10620-020-06071-2 contributor: fullname: Johnson – volume: 11 year: 2016 ident: R59 article-title: The impact of Azathioprine-Associated lymphopenia on the onset of opportunistic infections in patients with inflammatory bowel disease publication-title: PLoS One doi: 10.1371/journal.pone.0155218 contributor: fullname: Frei – volume: 369 start-page: 1641 year: 2007 ident: R1 article-title: Inflammatory bowel disease: clinical aspects and established and evolving therapies publication-title: Lancet doi: 10.1016/S0140-6736(07)60751-X contributor: fullname: Sandborn – volume: 19 start-page: 1411 year: 2013 ident: R28 article-title: Improving case definition of Crohn's disease and ulcerative colitis in electronic medical records using natural language processing: a novel informatics approach publication-title: Inflamm Bowel Dis doi: 10.1097/MIB.0b013e31828133fd contributor: fullname: Savova – volume: 153 start-page: 430 year: 2017 ident: R42 article-title: Higher incidence of Clostridium difficile infection among individuals with inflammatory bowel disease publication-title: Gastroenterology doi: 10.1053/j.gastro.2017.04.044 contributor: fullname: Yu – volume: 6 year: 2016 ident: R17 article-title: Royal College of general practitioners research and surveillance centre (RCGP RSC) sentinel network: a cohort profile publication-title: BMJ Open doi: 10.1136/bmjopen-2016-011092 contributor: fullname: McGovern – volume: 19 start-page: 127 year: 2011 ident: R18 article-title: Defining datasets and creating data dictionaries for quality improvement and research in chronic disease using routinely collected data: an ontology-driven approach publication-title: Inform Prim Care doi: 10.14236/jhi.v19i3.805 contributor: fullname: Michalakidis – volume: 113 start-page: 1530 year: 2018 ident: R44 article-title: Enteric infections are common in patients with flares of inflammatory bowel disease publication-title: Am J Gastroenterol doi: 10.1038/s41395-018-0211-8 contributor: fullname: Green – volume: 68 start-page: s1 year: 2019 ident: R43 article-title: British Society of gastroenterology consensus guidelines on the management of inflammatory bowel disease in adults publication-title: Gut doi: 10.1136/gutjnl-2019-318484 contributor: fullname: Raine – volume: 390 start-page: 2769 year: 2018 ident: R4 article-title: Worldwide incidence and prevalence of inflammatory bowel disease in the 21st century: a systematic review of population-based studies publication-title: Lancet doi: 10.1016/S0140-6736(17)32448-0 contributor: fullname: Hamidi – volume: 24 start-page: 2173 year: 2018 ident: R57 article-title: Herpes zoster in patients receiving JAK inhibitors for ulcerative colitis: mechanism, epidemiology, management, and prevention publication-title: Inflamm Bowel Dis doi: 10.1093/ibd/izy150 contributor: fullname: Colombel – volume: 53 start-page: 1471 year: 2004 ident: R3 article-title: Cost of illness of inflammatory bowel disease in the UK: a single centre retrospective study publication-title: Gut doi: 10.1136/gut.2004.041616 contributor: fullname: Williamson – volume: 20 start-page: 3255 year: 2014 ident: R47 article-title: Dysregulation of mucosal immune response in pathogenesis of inflammatory bowel disease publication-title: World J Gastroenterol doi: 10.3748/wjg.v20.i12.3255 contributor: fullname: Feng – volume: 20 start-page: 6 year: 2014 ident: R48 article-title: Immunopathology of inflammatory bowel disease publication-title: World J Gastroenterol doi: 10.3748/wjg.v20.i1.6 contributor: fullname: Kanazawa – volume: 155 start-page: 337 year: 2018 ident: R55 article-title: Risk of serious and opportunistic infections associated with treatment of inflammatory bowel diseases publication-title: Gastroenterology doi: 10.1053/j.gastro.2018.04.012 contributor: fullname: Carrat – volume: 107 start-page: 1409 year: 2012 ident: R12 article-title: Serious infection and mortality in patients with Crohn's disease: more than 5 years of follow-up in the TREAT™ registry publication-title: Am J Gastroenterol doi: 10.1038/ajg.2012.218 contributor: fullname: Cohen – volume: 6 year: 2020 ident: R24 article-title: Risk of venous thromboembolism in immune-mediated inflammatory diseases: a UK matched cohort study publication-title: RMD Open doi: 10.1136/rmdopen-2020-001392 contributor: fullname: Irving – volume: 5 start-page: 339 year: 2007 ident: R41 article-title: Incidence of Clostridium difficile infection in inflammatory bowel disease publication-title: Clin Gastroenterol Hepatol doi: 10.1016/j.cgh.2006.12.027 contributor: fullname: Reske – volume: 106 year: 2020 ident: R51 article-title: Cardiovascular risk factors and outcomes in early rheumatoid arthritis: a population-based study publication-title: Heart doi: 10.1136/heartjnl-2019-316193 contributor: fullname: Mallen – volume: 15 year: 2018 ident: R15 article-title: Lymphopenia and risk of infection and infection-related death in 98,344 individuals from a prospective Danish population-based study publication-title: PLoS Med doi: 10.1371/journal.pmed.1002685 contributor: fullname: Nordestgaard – volume: 37 start-page: 420 year: 2013 ident: R56 article-title: Increased risk of herpes zoster among 108 604 patients with inflammatory bowel disease publication-title: Aliment Pharmacol Ther doi: 10.1111/apt.12182 contributor: fullname: Sandler – volume: 67 start-page: e336 year: 2017 ident: R29 article-title: Clinical features of bowel disease in patients aged <50 years in primary care: a large case-control study publication-title: Br J Gen Pract doi: 10.3399/bjgp17X690425 contributor: fullname: Alsina – volume: 107 start-page: 1409 year: 2012 article-title: Serious infection and mortality in patients with Crohn's disease: more than 5 years of follow-up in the TREAT™ registry publication-title: Am J Gastroenterol doi: 10.1038/ajg.2012.218 contributor: fullname: Cohen – volume: 20 start-page: 970 year: 2019 article-title: Targeting immune cell circuits and trafficking in inflammatory bowel disease publication-title: Nat Immunol doi: 10.1038/s41590-019-0415-0 contributor: fullname: Neurath – volume: 53 start-page: 1471 year: 2004 article-title: Cost of illness of inflammatory bowel disease in the UK: a single centre retrospective study publication-title: Gut doi: 10.1136/gut.2004.041616 contributor: fullname: Williamson – volume: 360 year: 2018 article-title: Dipeptidyl peptidase-4 inhibitors and incidence of inflammatory bowel disease among patients with type 2 diabetes: population based cohort study publication-title: BMJ doi: 10.1136/bmj.k872 contributor: fullname: Yin – volume: 14 start-page: 203 year: 2006 article-title: Routinely collected general practice data: goldmines for research? A report of the European Federation for medical informatics primary care informatics Working Group (EFMI PCIWG) from MIE2006, Maastricht, the Netherlands publication-title: Inform Prim Care doi: 10.14236/jhi.v14i3.632 contributor: fullname: Houwink – volume: 37 start-page: 420 year: 2013 article-title: Increased risk of herpes zoster among 108 604 patients with inflammatory bowel disease publication-title: Aliment Pharmacol Ther doi: 10.1111/apt.12182 contributor: fullname: Sandler – volume: 23 start-page: 799 year: 2017 article-title: Ethnicity recording in primary care computerised medical record systems: an ontological approach publication-title: J Innov Health Inform doi: 10.14236/jhi.v23i4.920 contributor: fullname: Liyanage – volume: 5 year: 2015 article-title: A comparison of the recording of comorbidity in primary and secondary care by using the Charlson index to predict short-term and long-term survival in a routine linked data cohort publication-title: BMJ Open doi: 10.1136/bmjopen-2015-007974 contributor: fullname: Card – year: 2020 article-title: Common infections, mental health problems and healthcare use in people with inflammatory bowel disease: a cohort study protocol publication-title: Evid Based Ment Health doi: 10.1136/ebmental-2020-300167 contributor: fullname: Tang – volume: 106 start-page: 1566 year: 2020 article-title: Cardiovascular risk factors and outcomes in early rheumatoid arthritis: a population-based study publication-title: Heart doi: 10.1136/heartjnl-2019-316193 contributor: fullname: Mallen – volume: 65 start-page: 3287 year: 2020 article-title: Prevalence and effect of intestinal infections detected by a PCR-based stool test in patients with inflammatory bowel disease publication-title: Dig Dis Sci doi: 10.1007/s10620-020-06071-2 contributor: fullname: Johnson – volume: 108 start-page: 240 year: 2013 article-title: Increased risk of pneumonia among patients with inflammatory bowel disease publication-title: Am J Gastroenterol doi: 10.1038/ajg.2012.406 contributor: fullname: Sandler – volume: 106 year: 2020 article-title: Cardiovascular risk factors and outcomes in early rheumatoid arthritis: a population-based study publication-title: Heart doi: 10.1136/heartjnl-2019-316193 contributor: fullname: Mallen – volume: 20 start-page: 6 year: 2014 article-title: Immunopathology of inflammatory bowel disease publication-title: World J Gastroenterol doi: 10.3748/wjg.v20.i1.6 contributor: fullname: Kanazawa – volume: 30 start-page: 6 year: 2014 article-title: Infections and chronic inflammatory bowel disease publication-title: Viszeralmedizin doi: 10.1159/000366463 contributor: fullname: Maaser – volume: 39 start-page: 219 year: 2020 article-title: Increased risk of herpes zoster infection in patients with inflammatory bowel disease: a meta-analysis of cohort studies publication-title: Eur J Clin Microbiol Infect Dis doi: 10.1007/s10096-019-03706-9 contributor: fullname: Li – volume: 19 start-page: 127 year: 2011 article-title: Defining datasets and creating data dictionaries for quality improvement and research in chronic disease using routinely collected data: an ontology-driven approach publication-title: Inform Prim Care doi: 10.14236/jhi.v19i3.805 contributor: fullname: Michalakidis – volume: 5 start-page: 18 year: 2008 article-title: Infections and IBD publication-title: Nat Clin Pract Gastroenterol Hepatol doi: 10.1038/ncpgasthep1004 contributor: fullname: Gibson – volume: 36 start-page: 321 year: 2017 article-title: ESPEN guideline: clinical nutrition in inflammatory bowel disease publication-title: Clin Nutr doi: 10.1016/j.clnu.2016.12.027 contributor: fullname: Hébuterne – volume: 23 start-page: 253 year: 2006 article-title: The use of routinely collected computer data for research in primary care: opportunities and challenges publication-title: Fam Pract doi: 10.1093/fampra/cmi106 contributor: fullname: van Weel – volume: 11 start-page: S338 year: 2017 article-title: P509 IBD cancer and serious infections in Europe (I-care): a European prospective observational study publication-title: Journal of Crohn’s and Colitis – volume: 67 start-page: e336 year: 2017 article-title: Clinical features of bowel disease in patients aged <50 years in primary care: a large case-control study publication-title: Br J Gen Pract doi: 10.3399/bjgp17X690425 contributor: fullname: Alsina – volume: 41 start-page: 1625 year: 2012 article-title: Data resource profile: cardiovascular disease research using linked bespoke studies and electronic health records (caliber) publication-title: Int J Epidemiol doi: 10.1093/ije/dys188 contributor: fullname: Herrett – volume: 369 start-page: 1641 year: 2007 article-title: Inflammatory bowel disease: clinical aspects and established and evolving therapies publication-title: Lancet doi: 10.1016/S0140-6736(07)60751-X contributor: fullname: Sandborn – volume: 50 start-page: 198 year: 2013 article-title: Evaluation and management of patients with isolated neutropenia publication-title: Semin Hematol doi: 10.1053/j.seminhematol.2013.06.010 contributor: fullname: Dale – volume: 8 start-page: 443 year: 2014 article-title: Second European evidence-based consensus on the prevention, diagnosis and management of opportunistic infections in inflammatory bowel disease publication-title: J Crohns Colitis doi: 10.1016/j.crohns.2013.12.013 contributor: fullname: Abreu – volume: 4 start-page: 1483 year: 2006 article-title: Incidence and risk factors for herpes zoster among patients with inflammatory bowel disease publication-title: Clin Gastroenterol Hepatol doi: 10.1016/j.cgh.2006.09.019 contributor: fullname: Lewis – volume: 134 start-page: 929 year: 2008 article-title: Risk factors for opportunistic infections in patients with inflammatory bowel disease publication-title: Gastroenterology doi: 10.1053/j.gastro.2008.01.012 contributor: fullname: Harmsen – volume: 11 year: 2016 article-title: The impact of Azathioprine-Associated lymphopenia on the onset of opportunistic infections in patients with inflammatory bowel disease publication-title: PLoS One doi: 10.1371/journal.pone.0155218 contributor: fullname: Frei – volume: 11 year: 2020 article-title: Time- and race-specific haematological reference intervals for healthy volunteer trials: a retrospective analysis of pooled data from multiple phase I trials publication-title: Front Pharmacol doi: 10.3389/fphar.2020.00314 contributor: fullname: Pierscionek – volume: 20 start-page: 639 year: 2002 article-title: Cost of illness of Crohn's disease publication-title: Pharmacoeconomics doi: 10.2165/00019053-200220100-00001 contributor: fullname: Bodger – volume: 6 year: 2020 article-title: Risk of venous thromboembolism in immune-mediated inflammatory diseases: a UK matched cohort study publication-title: RMD Open doi: 10.1136/rmdopen-2020-001392 contributor: fullname: Irving – volume: 153 start-page: 430 year: 2017 article-title: Higher incidence of Clostridium difficile infection among individuals with inflammatory bowel disease publication-title: Gastroenterology doi: 10.1053/j.gastro.2017.04.044 contributor: fullname: Yu – volume: 24 start-page: 2173 year: 2018 article-title: Herpes zoster in patients receiving JAK inhibitors for ulcerative colitis: mechanism, epidemiology, management, and prevention publication-title: Inflamm Bowel Dis doi: 10.1093/ibd/izy150 contributor: fullname: Colombel – volume: 69 start-page: 984 year: 2020 article-title: British Society of gastroenterology guidance for management of inflammatory bowel disease during the COVID-19 pandemic publication-title: Gut doi: 10.1136/gutjnl-2020-321244 contributor: fullname: Lamb – volume: 5 start-page: 339 year: 2007 article-title: Incidence of Clostridium difficile infection in inflammatory bowel disease publication-title: Clin Gastroenterol Hepatol doi: 10.1016/j.cgh.2006.12.027 contributor: fullname: Reske – volume: 105 start-page: 371 year: 2010 article-title: Increased prevalence of and associated mortality with methicillin-resistant Staphylococcus aureus among hospitalized IBD patients publication-title: Am J Gastroenterol doi: 10.1038/ajg.2009.581 contributor: fullname: Chong – volume: 17 start-page: 1338 year: 2011 article-title: Increased risk of vancomycin-resistant Enterococcus (VRE) infection among patients hospitalized for inflammatory bowel disease in the United States publication-title: Inflamm Bowel Dis doi: 10.1002/ibd.21519 contributor: fullname: Weizman – volume: 3 start-page: e82 year: 2018 article-title: Evaluation of the effect of the herpes zoster vaccination programme 3 years after its introduction in England: a population-based study publication-title: Lancet Public Health doi: 10.1016/S2468-2667(17)30234-7 contributor: fullname: Keel – volume: 24 start-page: 2258 year: 2018 article-title: Herpes zoster infection in patients with ulcerative colitis receiving tofacitinib publication-title: Inflamm Bowel Dis doi: 10.1093/ibd/izy131 contributor: fullname: Vermeire – volume: 14 start-page: 1443 year: 2008 article-title: Phagocyte dysfunction and inflammatory bowel disease publication-title: Inflamm Bowel Dis doi: 10.1002/ibd.20449 contributor: fullname: Hayee – volume: 44 start-page: 482 year: 2016 article-title: Steroid dependency and trends in prescribing for inflammatory bowel disease - a 20-year national population-based study publication-title: Aliment Pharmacol Ther doi: 10.1111/apt.13700 contributor: fullname: Cecil – volume: 155 start-page: 337 year: 2018 article-title: Risk of serious and opportunistic infections associated with treatment of inflammatory bowel diseases publication-title: Gastroenterology doi: 10.1053/j.gastro.2018.04.012 contributor: fullname: Carrat – volume: 67 start-page: e29 year: 2017 article-title: RCGP research and surveillance centre annual report 2014-2015: disparities in presentations to primary care publication-title: Br J Gen Pract doi: 10.3399/bjgp16X688573 contributor: fullname: Pathirannehelage – volume: 16 start-page: 528 year: 2018 article-title: Non-Clostridium difficile bacterial infections are rare in patients with flares of inflammatory bowel disease publication-title: Clin Gastroenterol Hepatol doi: 10.1016/j.cgh.2017.10.008 contributor: fullname: Loftus – volume: 4 start-page: 621 year: 2006 article-title: Serious infections and mortality in association with therapies for Crohn's disease: treat registry publication-title: Clin Gastroenterol Hepatol doi: 10.1016/j.cgh.2006.03.002 contributor: fullname: Cohen – volume: 15 year: 2018 article-title: Lymphopenia and risk of infection and infection-related death in 98,344 individuals from a prospective Danish population-based study publication-title: PLoS Med doi: 10.1371/journal.pmed.1002685 contributor: fullname: Nordestgaard – volume: 247 start-page: 161 year: 2018 article-title: Uptake of a Dashboard designed to give RealTime feedback to a sentinel network about key data required for influenza vaccine effectiveness studies publication-title: Stud Health Technol Inform contributor: fullname: Byford – volume: 113 start-page: 1530 year: 2018 article-title: Enteric infections are common in patients with flares of inflammatory bowel disease publication-title: Am J Gastroenterol doi: 10.1038/s41395-018-0211-8 contributor: fullname: Green – volume: 7 start-page: 107 year: 2013 article-title: Infection-related hospitalizations are associated with increased mortality in patients with inflammatory bowel diseases publication-title: J Crohns Colitis doi: 10.1016/j.crohns.2012.02.015 contributor: fullname: McGinley – volume: 13 year: 2016 article-title: Common infections in patients prescribed systemic glucocorticoids in primary care: a population-based cohort study publication-title: PLoS Med doi: 10.1371/journal.pmed.1002024 contributor: fullname: Nazareth – year: 2019 article-title: Haematological abnormalities in new-onset rheumatoid arthritis and risk of common infections: a population-based study publication-title: Rheumatology contributor: fullname: Mallen – volume: 6 year: 2016 article-title: Royal College of general practitioners research and surveillance centre (RCGP RSC) sentinel network: a cohort profile publication-title: BMJ Open doi: 10.1136/bmjopen-2016-011092 contributor: fullname: McGovern – volume: 390 start-page: 2769 year: 2018 article-title: Worldwide incidence and prevalence of inflammatory bowel disease in the 21st century: a systematic review of population-based studies publication-title: Lancet doi: 10.1016/S0140-6736(17)32448-0 contributor: fullname: Hamidi – volume: 20 start-page: 3255 year: 2014 article-title: Dysregulation of mucosal immune response in pathogenesis of inflammatory bowel disease publication-title: World J Gastroenterol doi: 10.3748/wjg.v20.i12.3255 contributor: fullname: Feng – volume: 109 start-page: 1795 year: 2014 article-title: Oral corticosteroids and the risk of serious infections in patients with elderly-onset inflammatory bowel diseases publication-title: Am J Gastroenterol doi: 10.1038/ajg.2014.313 contributor: fullname: Suissa – volume: 68 start-page: s1 year: 2019 article-title: British Society of gastroenterology consensus guidelines on the management of inflammatory bowel disease in adults publication-title: Gut doi: 10.1136/gutjnl-2019-318484 contributor: fullname: Raine – volume: 19 start-page: 1411 year: 2013 article-title: Improving case definition of Crohn's disease and ulcerative colitis in electronic medical records using natural language processing: a novel informatics approach publication-title: Inflamm Bowel Dis doi: 10.1097/MIB.0b013e31828133fd contributor: fullname: Savova – volume: 108 start-page: 1268 year: 2013 article-title: Opportunistic infections with anti-tumor necrosis factor-α therapy in inflammatory bowel disease: meta-analysis of randomized controlled trials publication-title: Am J Gastroenterol doi: 10.1038/ajg.2013.138 contributor: fullname: Peyrin-Biroulet – volume: 391 start-page: 1097 year: 2018 article-title: Disease burden and costs from excess alcohol consumption, obesity, and viral hepatitis: fourth report of the Lancet standing Commission on liver disease in the UK publication-title: Lancet doi: 10.1016/S0140-6736(17)32866-0 contributor: fullname: Armstrong – volume: 40 start-page: 1486 year: 2017 article-title: Incidence, demographics, and clinical characteristics of diabetes of the exocrine pancreas (type 3C): a retrospective cohort study publication-title: Diabetes Care doi: 10.2337/dc17-0542 contributor: fullname: McCullough – ident: 2024051413253676000_8.1.e000573.38 doi: 10.1038/ajg.2009.581 – ident: 2024051413253676000_8.1.e000573.55 doi: 10.1053/j.gastro.2018.04.012 – ident: 2024051413253676000_8.1.e000573.22 doi: 10.1016/S0140-6736(17)32866-0 – volume: 11 start-page: S338 year: 2017 ident: 2024051413253676000_8.1.e000573.53 article-title: P509 IBD cancer and serious infections in Europe (I-care): a European prospective observational study publication-title: Journal of Crohn’s and Colitis – ident: 2024051413253676000_8.1.e000573.34 doi: 10.1093/ije/dys188 – ident: 2024051413253676000_8.1.e000573.56 doi: 10.1111/apt.12182 – ident: 2024051413253676000_8.1.e000573.18 doi: 10.14236/jhi.v19i3.805 – ident: 2024051413253676000_8.1.e000573.54 doi: 10.1038/ajg.2013.138 – ident: 2024051413253676000_8.1.e000573.35 doi: 10.1007/978-1-4757-3294-8 – ident: 2024051413253676000_8.1.e000573.48 doi: 10.3748/wjg.v20.i1.6 – ident: 2024051413253676000_8.1.e000573.37 doi: 10.1002/ibd.21519 – ident: 2024051413253676000_8.1.e000573.12 doi: 10.1038/ajg.2012.218 – volume: 65 start-page: 3287 year: 2020 ident: 2024051413253676000_8.1.e000573.40 article-title: Prevalence and effect of intestinal infections detected by a PCR-based stool test in patients with inflammatory bowel disease publication-title: Dig Dis Sci doi: 10.1007/s10620-020-06071-2 contributor: fullname: Limsrivilai – ident: 2024051413253676000_8.1.e000573.4 doi: 10.1016/S0140-6736(17)32448-0 – ident: 2024051413253676000_8.1.e000573.44 doi: 10.1038/s41395-018-0211-8 – volume: 24 start-page: 2173 year: 2018 ident: 2024051413253676000_8.1.e000573.57 article-title: Herpes zoster in patients receiving JAK inhibitors for ulcerative colitis: mechanism, epidemiology, management, and prevention publication-title: Inflamm Bowel Dis doi: 10.1093/ibd/izy150 contributor: fullname: Colombel – volume: 24 start-page: 2258 year: 2018 ident: 2024051413253676000_8.1.e000573.58 article-title: Herpes zoster infection in patients with ulcerative colitis receiving tofacitinib publication-title: Inflamm Bowel Dis doi: 10.1093/ibd/izy131 contributor: fullname: Winthrop – ident: 2024051413253676000_8.1.e000573.41 doi: 10.1016/j.cgh.2006.12.027 – ident: 2024051413253676000_8.1.e000573.11 doi: 10.1016/j.cgh.2006.03.002 – ident: 2024051413253676000_8.1.e000573.28 doi: 10.1097/MIB.0b013e31828133fd – ident: 2024051413253676000_8.1.e000573.13 doi: 10.1038/ajg.2012.406 – volume: 16 start-page: 528 year: 2018 ident: 2024051413253676000_8.1.e000573.45 article-title: Non-Clostridium difficile bacterial infections are rare in patients with flares of inflammatory bowel disease publication-title: Clin Gastroenterol Hepatol doi: 10.1016/j.cgh.2017.10.008 contributor: fullname: Hanada – ident: 2024051413253676000_8.1.e000573.1 doi: 10.1016/S0140-6736(07)60751-X – ident: 2024051413253676000_8.1.e000573.25 doi: 10.3399/bjgp16X688573 – ident: 2024051413253676000_8.1.e000573.3 doi: 10.1136/gut.2004.041616 – ident: 2024051413253676000_8.1.e000573.17 doi: 10.1136/bmjopen-2016-011092 – ident: 2024051413253676000_8.1.e000573.29 doi: 10.3399/bjgp17X690425 – ident: 2024051413253676000_8.1.e000573.59 doi: 10.1371/journal.pone.0155218 – volume: 13 year: 2016 ident: 2024051413253676000_8.1.e000573.62 article-title: Common infections in patients prescribed systemic glucocorticoids in primary care: a population-based cohort study publication-title: PLoS Med doi: 10.1371/journal.pmed.1002024 contributor: fullname: Fardet – volume: 247 start-page: 161 year: 2018 ident: 2024051413253676000_8.1.e000573.27 article-title: Uptake of a Dashboard designed to give RealTime feedback to a sentinel network about key data required for influenza vaccine effectiveness studies publication-title: Stud Health Technol Inform contributor: fullname: Pathirannehelage – ident: 2024051413253676000_8.1.e000573.52 doi: 10.1093/rheumatology/kez344 – ident: 2024051413253676000_8.1.e000573.33 doi: 10.1053/j.seminhematol.2013.06.010 – ident: 2024051413253676000_8.1.e000573.43 doi: 10.1136/gutjnl-2019-318484 – ident: 2024051413253676000_8.1.e000573.46 doi: 10.1002/ibd.20449 – ident: 2024051413253676000_8.1.e000573.2 doi: 10.2165/00019053-200220100-00001 – volume: 14 start-page: 203 year: 2006 ident: 2024051413253676000_8.1.e000573.20 article-title: Routinely collected general practice data: goldmines for research? A report of the European Federation for medical informatics primary care informatics Working Group (EFMI PCIWG) from MIE2006, Maastricht, the Netherlands publication-title: Inform Prim Care contributor: fullname: de Lusignan – ident: 2024051413253676000_8.1.e000573.23 doi: 10.2337/dc17-0542 – ident: 2024051413253676000_8.1.e000573.30 doi: 10.1136/bmj.k872 – ident: 2024051413253676000_8.1.e000573.36 doi: 10.1016/j.crohns.2013.12.013 – ident: 2024051413253676000_8.1.e000573.50 doi: 10.1038/ncpgasthep1004 – ident: 2024051413253676000_8.1.e000573.63 doi: 10.1016/j.clnu.2016.12.027 – volume: 30 start-page: 6 year: 2014 ident: 2024051413253676000_8.1.e000573.6 article-title: Infections and chronic inflammatory bowel disease publication-title: Viszeralmedizin contributor: fullname: Kucharzik – ident: 2024051413253676000_8.1.e000573.31 – ident: 2024051413253676000_8.1.e000573.26 doi: 10.1016/S2468-2667(17)30234-7 – volume: 44 start-page: 482 year: 2016 ident: 2024051413253676000_8.1.e000573.61 article-title: Steroid dependency and trends in prescribing for inflammatory bowel disease - a 20-year national population-based study publication-title: Aliment Pharmacol Ther doi: 10.1111/apt.13700 contributor: fullname: Chhaya – ident: 2024051413253676000_8.1.e000573.47 doi: 10.3748/wjg.v20.i12.3255 – ident: 2024051413253676000_8.1.e000573.9 doi: 10.1136/bmjopen-2015-007974 – ident: 2024051413253676000_8.1.e000573.49 doi: 10.1016/j.crohns.2012.02.015 – ident: 2024051413253676000_8.1.e000573.24 doi: 10.1136/rmdopen-2020-001392 – ident: 2024051413253676000_8.1.e000573.14 doi: 10.1016/j.cgh.2006.09.019 – ident: 2024051413253676000_8.1.e000573.8 doi: 10.1136/gutjnl-2020-321244 – volume: 20 start-page: 970 year: 2019 ident: 2024051413253676000_8.1.e000573.5 article-title: Targeting immune cell circuits and trafficking in inflammatory bowel disease publication-title: Nat Immunol doi: 10.1038/s41590-019-0415-0 contributor: fullname: Neurath – volume: 109 start-page: 1795 year: 2014 ident: 2024051413253676000_8.1.e000573.10 article-title: Oral corticosteroids and the risk of serious infections in patients with elderly-onset inflammatory bowel diseases publication-title: Am J Gastroenterol doi: 10.1038/ajg.2014.313 contributor: fullname: Brassard – volume: 23 start-page: 799 year: 2017 ident: 2024051413253676000_8.1.e000573.32 article-title: Ethnicity recording in primary care computerised medical record systems: an ontological approach publication-title: J Innov Health Inform doi: 10.14236/jhi.v23i4.920 contributor: fullname: Tippu – ident: 2024051413253676000_8.1.e000573.19 doi: 10.1093/fampra/cmi106 – ident: 2024051413253676000_8.1.e000573.21 doi: 10.1136/heartjnl-2019-316193 – volume: 11 year: 2020 ident: 2024051413253676000_8.1.e000573.60 article-title: Time- and race-specific haematological reference intervals for healthy volunteer trials: a retrospective analysis of pooled data from multiple phase I trials publication-title: Front Pharmacol doi: 10.3389/fphar.2020.00314 contributor: fullname: Coates – ident: 2024051413253676000_8.1.e000573.7 doi: 10.1053/j.gastro.2008.01.012 – volume: 153 start-page: 430 year: 2017 ident: 2024051413253676000_8.1.e000573.42 article-title: Higher incidence of Clostridium difficile infection among individuals with inflammatory bowel disease publication-title: Gastroenterology doi: 10.1053/j.gastro.2017.04.044 contributor: fullname: Singh – volume: 106 year: 2020 ident: 2024051413253676000_8.1.e000573.51 article-title: Cardiovascular risk factors and outcomes in early rheumatoid arthritis: a population-based study publication-title: Heart doi: 10.1136/heartjnl-2019-316193 contributor: fullname: Nikiphorou – volume: 39 start-page: 219 year: 2020 ident: 2024051413253676000_8.1.e000573.39 article-title: Increased risk of herpes zoster infection in patients with inflammatory bowel disease: a meta-analysis of cohort studies publication-title: Eur J Clin Microbiol Infect Dis doi: 10.1007/s10096-019-03706-9 contributor: fullname: Ning – ident: 2024051413253676000_8.1.e000573.15 doi: 10.1371/journal.pmed – year: 2020 ident: 2024051413253676000_8.1.e000573.16 article-title: Common infections, mental health problems and healthcare use in people with inflammatory bowel disease: a cohort study protocol publication-title: Evid Based Ment Health contributor: fullname: Irving |
SSID | ssj0001534228 |
Score | 2.384354 |
Snippet | ObjectiveTo evaluate the risk of common infections in individuals with inflammatory bowel disease (IBD) [ulcerative colitis and Crohn’s disease] compared with... To evaluate the risk of common infections in individuals with inflammatory bowel disease (IBD) [ulcerative colitis and Crohn's disease] compared with matched... Objective To evaluate the risk of common infections in individuals with inflammatory bowel disease (IBD) [ulcerative colitis and Crohn’s disease] compared with... OBJECTIVETo evaluate the risk of common infections in individuals with inflammatory bowel disease (IBD) [ulcerative colitis and Crohn's disease] compared with... Objective To evaluate the risk of common infections in individuals with inflammatory bowel disease (IBD) [ulcerative colitis and Crohn’s disease] compared with... |
SourceID | doaj pubmedcentral proquest crossref pubmed bmj |
SourceType | Open Website Open Access Repository Aggregation Database Index Database Publisher |
StartPage | e000573 |
SubjectTerms | Chronic illnesses Chronic obstructive pulmonary disease Codes Cohort analysis Comorbidity Coronaviruses COVID-19 Crohn's disease Epidemiology Herpes viruses Infections Infectious diseases Inflammatory bowel disease Laboratories Neutropenia Pandemics Pneumonia Population Population-based studies Primary care Surveillance ulcerative colitis Viral infections |
SummonAdditionalLinks | – databaseName: BMJ Journals (Open Access) dbid: 9YT link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV3Nb9UwDLdgSIgL4nuFgYKEBAcqmqRJ2t0GYpqQxgFt0jhVSZPAGOtDe53497HTvLcVMbRb1bhVE9v1z7FjA7zyXLeGc1-KyF1Z-1iVDY-u7HsjYgitEoEOOO9_1nuH9acjdXTpsPo8gs-lfudOf3yzyxHZKdIZaGXkTbglEOemhgVfDy62VJSkgla5ttAVz6INwbszK5SK9f8LYf6dKHnJ8uzeg7sZMrKdicf34UYYHsDt_RwUfwjjl-PlCVtEhsKDQsVW-VXDEi_ZlCLOaL-VRlAATlNgnbnF7_CT5QBNopwKTzBKBttmlv1a9_YqydZ5Rs10z0aWKtI-gsPdjwcf9srcTKF06KOMpax7YfEv29aNdML2zojgq8gb1MrQOKUiOj6iN61HBBZCIz26hj6I6KXGJyr5GDaGxRA2gSGqCRbNGg811XcLCHF42_PW4zI7w2MBb3CJu6wMyy75GVJ3mRsdcaObuFHAayLNE_w_5dsVx65H_p64uialKtrpBopWl5Wy6y13UYqoJYJgoyvLrTVG-1grXKy-KWBrJRMXs0F_tUIMqZsrhlXTUp2_qi3g5XoYdZYCMXYIi_P0CvS6qUlUAU8mCVt_qJTo4iGoKsDMZG82k_nIcPw91QU3iD21Ek-vvabP4I6gFB3qb2O2YGM8Ow_PEWON7kXSrD_KZiHQ priority: 500 providerName: BMJ Publishing Group Ltd – databaseName: DOAJ Directory of Open Access Journals dbid: DOA link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Nb9QwEB1BD4gL4ptAQUZCggNRYzu2E26AqCqkckBU6i2yYxtaaBZ1U_H3mbG9yy7i68BtFU9W8fg5fhOP3wA88Vz3hnNfi8hd3frY1B2Prh5HI2IIvRKBDjgfvtMHR-3bY3W8UeqLcsKyPHB23N5ouYtSRC2RqBjdWG6tMdrHVo3CjvmYL1cbwVQ-HyxJ26rIDHGp99zZ6Ue7nBEVIh2lVlQp_TJe3VqQkm7_r8jmzzmTG4vQ_nW4Vtgje5mf-gZcCtNNuHJY9sdvwfz-ZPmZLSJDHCG-2CrValriT5azxRl9eqUWxMJZ2mNnbvEtfGFlryZZZg0KRnlhL5hlX9dlvmpa9jyjurrnM0vitLfhaP_Nh9cHdamrUDsMV-Zatug5fOH2bScd-tAZEXwTeYcTNHROqYgxkBhN75GMhdBJjx72QUQvNd7RyDuwMy2mcA8YEpxgcYXjoSWpt4Bsh_cj7z262RkeK3iGLh7KvFgOKeSQeiijMdBoDHk0KnhKpqWDf7Z8vhqxfzN_RaO6NiVB7XQBYTYUmA1_g1kFuytM_OgNhq4N0knd_aZZdT1J_jV9BY_XzTh9aU_GTmFxkf4CA3CqF1XB3Yyw9YNKidEe8qsKzBb2tnqy3TKdfEoS4QZpqFbi_v_o-gO4KiiRh6rgmF3Ymc8vwkNkYrN7lCbddxEgMOw priority: 102 providerName: Directory of Open Access Journals – databaseName: ProQuest Central dbid: BENPR link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV3_a9UwEA_7AuIv4nerUyII-oPlNUmbtP4iTjYewoYMB_ut5Os2de18r8N_37s0r_OJDn8rzbUkubvkc7nLHSGvHJONYszlPDCTly4Uec2Cya1VPHjfVNzjBeeDQzk_Lj-dVCcbZL66C4Nhlas1MS7Urrd4Rj7jVd1g_rSimWmDpwB2mL2__JFj_Sj0s6ZiGptkm7MSHbbbu3uHn4-uz1sqgdmuUuIhJuTMXHw91csB5ITHy9UV1k7fhLdrW1TM5P83-PlnFOVv29L-XXIn4Un6YRSAe2TDd_fJrYPkMX9AhqPz5TfaBwqjhI7TVfBVt4RHOsaPUzyMxRaQjovodaem_-m_0-S9iZRjVgqKkWLvqKaXU-GvHDdCR7HS7mKgMV3tQ3K8v_fl4zxPlRZyAwbMkIvScg1LcFPWwnBtjeLeFYHVoLK-NlUVwCriVjUO4Jn3tXBgNzrPgxMSvijEI7LV9Z1_QihAHq9hz2O-xORvHvAPayxrHEyzUSxk5A1McZs0ZdlGI0TINnGjRW60Izcy8hpJ0wBvpny74tj_ke8iVydSTLEdX_SL0zZpbGs1M0HwIAUgZCULzbRWSrpQVjBZts7IzkomrkcDxmwBAFPW_2iehDgjL6dmUGj00ujO91fxF2CSYwWpjDweJWzqqBBg_wHiyohak721kay3dOdnMWm4AmAqK_705m49I7c5Bu1gxRu1Q7aGxZV_DqhrMC-SQv0Cdj0tKg priority: 102 providerName: ProQuest – databaseName: Scholars Portal Open Access Journals dbid: M48 link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV3di9QwEB_OE8QX8fys3kkEQR-sNknbtIKIischrA_iwr2VpEnO-2p1t4f63zuTpqsrd3JvSzPtbjK_6fxmM5kBeGJ5WSvObSo8N2lufZZW3Ju0bZXwztWFcHTAefap3JvnH_eL_Q2YuqLGBVyeG9pRP6n54uTFz--_3qDBv44dSV6a06MDvRxQ4SKcki6UvAJXRS5zgvws8v3x2LCkklfUcA6pSpoj94mViC54DnocvLrms0Jp__P46L9plX_5qd2bcCMSTPZ2RMQWbLjuFlybxS302zB8Plwes94zhBpCkE3ZWN0SP7IxoZzRv7M0gnA5DdvwzPQ_3AmL2zlBcixTwSh17BXT7NuqE1hKntEyar27GFioX3sH5rsfvrzfS2PrhdRgRDOkMm-FxndynVfSCN0aJZzNPK_Qhl1lisJjmCRaVVvka85V0mIgaZ3wVpZ4RybvwmbXd-4-MORATqMT5C6nanAOCRGvW15bXGajuE_gGS5xM2m-CVGJLJuojYa00YzaSOApicYJ_l_y-aSxy4m_I62uRKnmdrjQLw6aaMJNq7nxUvhSImxUmWmutVKl9XmBi9VWCWxPmPgzG4xuM2ScZXXBcFHVVBUwqxN4vBpGC6dtG925_iw8AmN0aimVwL0RYasfKiUGhEjBElBr2FubyfpId_g1VBFXyFTLQjy4xPc-hOuCUnmoD47ahs1hceZ2kIsN5lGwr98kATB_ priority: 102 providerName: Scholars Portal |
Title | Risk of common infections in people with inflammatory bowel disease in primary care: a population-based cohort study |
URI | http://dx.doi.org/10.1136/bmjgast-2020-000573 https://www.ncbi.nlm.nih.gov/pubmed/33597152 https://www.proquest.com/docview/2490441688/abstract/ https://www.proquest.com/docview/2589008709/abstract/ https://search.proquest.com/docview/2491072832 https://pubmed.ncbi.nlm.nih.gov/PMC7893652 https://doaj.org/article/ca1bf32f63774760a1aa776df45c2ac8 |
Volume | 8 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3db9MwELfWISFeJr7JGJWRkOCBrLGd2AlvW7VpQso0TRsqT5Ed26OwJlObiX-fs-OUFQFCvKRRfYli313ud_F9IPRGE14IQnRMLVFxqm0S58SquK4FtcYUGTUuwbk85SeX6cdZNttC2ZAL44P2azXfb64X-838i4-tvFnUkyFObHJWTgUYWZ7RyQiNBGN3XPQ-NZi5slahwhBhfKIWX6_kqgOBoD6LOhOuew5jgKWJSzgaAcGGWfLV-38HOX-NnLxjio4fop2AIfFB_6yP0JZpHqP7Zdglf4K68_nqG24tBmkCKcNDwFWzglPcx4xj9wHWjYBELPxOO1btd3ONw46Np-wrUWAXHfYBS3yzbvYVO-Onseuuu-ywL1H7FF0eH11MT-LQXSFW4LR0MUtrKuG1W6Q5U1TWSlCjE0tyUFOTqyyz4AnRWhQaIJkxOdPgK2pDrWYcrkjYM7TdtI15gTDAHCPBzhGTuoJvBjAPKWpSaFhxJYiN0DtY4ipox6ryjgfjVWBM5RhT9YyJ0FtHGib4d8r3A8f-jfzQcXVN6spq-z_a5VUVhKuqJVGWUcsZoGLBE0mkFIJrm2awWHUeob1BJn7OBhzYBEAlz_8wnOWFK_yXFBF6vR4GJXY7M7Ix7a2_BbjhrmtUhJ73ErZ-0EFOIyQ2ZG9jJpsjoDe-UHjQk93_vvIlekBdDI9rgCP20Ha3vDWvAIR1agyqNxNwLD5fjNG9g2lZfoLfw6PTs_Ox_7ABxzLNx145fwDeFzf4 |
link.rule.ids | 230,315,733,786,790,870,891,2115,2236,12083,21416,24346,27582,27583,27889,27957,27958,31754,31755,33779,33780,43345,43840,53827,53829,55704,55705,74102,74659 |
linkProvider | National Library of Medicine |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV3db9QwDI_YTYK9ID5HYUCQkOCBak3SJi0viKFNB-xOaNqkvVVNk4wN1o5rJ_597DTXcQgm3qrGrZLYTn6OHZuQl4bJQjFmYu6YjlPjkjhnTsd1rbiztsi4xQvOs7mcHqWfjrPjcODWhbDK5ZroF2rT1nhGvs2zvMD8aUnx7uJHjFWj0LsaSmiskfVUgKkyIes7u_MvB1enLJnAHFch3RATclufn51UXQ_Swf2V6gwrpq_B25WNyefv_xvo_DN28rfNaO8OuR1QJH0_sP0uuWGbe-TmLPjJ75P-4LT7RltHYWzQcboMuWo6eKRD1DjFI1hsAZk49752qtuf9jsNPhtPOeSioBgf9pZW9GIs9xXj9mco1tdd9NQnqX1AjvZ2Dz9M41BfIdZgtvSxSGtewcJbpLnQvKq14tYkjuWgqDbXWebAFuK1KgyAMmtzYcBaNJY7IyR8kYiHZNK0jX1EKAAdW8FOx2yKKd8soB5W1KwwMM1aMReR1zDFZdCPrvSmh5Bl4EaJ3CgHbkTkFZKGAV5P-WbJsf8j30GujqSYWNu_aBcnZdDTsq6YdoI7KQAXK5lUrKqUksalGUxWnUdkaykTV6MBEzYBWCnzfzSPohuRF2MzqDH6ZqrGtpf-F2CIY92oiGwOEjZ2VAiw-gBnRUStyN7KSFZbmtOvPlW4AjgqM_74-m49J7emh7P9cv_j_PMTssExbAdr3qgtMukXl_Yp4K5ePwvK9QuEAixd |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV3db9QwDI_YkCZeEN8UBgQJCR6orknapOUF8XUaH5sQYtK9VUmTjLGtHddO_PvYaa7jEEy8nRr3lMR2_HPs2oQ8sUxWijGbcs9MmlufpSXzJm0axb1zVcEdfuC8uyd39vMPi2IR85_6mFa5OhPDQW27Bu_IZ7woK6yfllUzH9MiPr-dvzz9kWIHKYy0xnYaG-QyWMkMuxmohTq_bykEVruKhYeYkDNz8v1A9wPICQ8fVxfYO30Dnq6ZqFDJ_2_w888syt_M0vwauRrxJH01CsB1csm1N8jWboyY3yTDl8P-iHaewiph2nSVfNX28JOO-eMUL2NxBKTjJETdqel-umMaozeBcqxKQTFT7AXV9HRq_JWiIbQUO-0uBxrK1d4i-_N3X9_spLHTQmrAgRlSkTdcwxFc5aUwXDdGcWczz0pQWVeaovDgFfFGVRbgmXOlsOA3Wse9FRLeyMRtstl2rbtLKEAep8HmMZdj8TcH-IdVDassbLNRzCfkGWxxHTWlr4MTImQduVEjN-qRGwl5iqRxgRdTPl9x7P_IXyNXJ1IssR0edMuDOmps3WhmvOBeCkDISmaaaa2UtD4vYLOaMiHbK5k4Xw04sxkATFn-Y3gS4oQ8noZBoTFKo1vXnYW_AJccO0gl5M4oYdNEhQD_DxBXQtSa7K2tZH2kPfwWioYrAKay4PcuntYjsgVaVX96v_fxPrnCMX8Hm9-obbI5LM_cAwBgg3kYNOsXjQ0vIw |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Risk+of+common+infections+in+people+with+inflammatory+bowel+disease+in+primary+care%3A+a+population-based+cohort+study&rft.jtitle=BMJ+open+gastroenterology&rft.au=Irving%2C+Peter+M&rft.au=de+Lusignan%2C+Simon&rft.au=Tang%2C+Daniel&rft.au=Nijher%2C+Monica&rft.date=2021-02-17&rft.issn=2054-4774&rft.eissn=2054-4774&rft.volume=8&rft.issue=1&rft_id=info:doi/10.1136%2Fbmjgast-2020-000573&rft.externalDBID=NO_FULL_TEXT |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2054-4774&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2054-4774&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2054-4774&client=summon |